Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 182

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels

Open access
Grebely, Jason, Oser, Megan, Taylor, Lynn E., Dore, Gregory J. · 2013 · The Journal of Infectious Diseases

Abstract

The majority of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection occurs among persons who inject drugs. Rapid improvements in responses to HCV therapy have been observed, but liver-related morbidity rates remain high, given notoriously low uptake of HCV treatment. Advances in HCV therapy will have a limited impact on the burden of HCV-related disease at the population-level unless barriers to HCV education, screening, evaluation, and treatment are addressed and treatment uptake increases. This review will outline barriers to HCV care in HCV/HIV coinfection, with a particular emphasis on persons who inject drugs, proposing strategies to enhance HCV treatment uptake and outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jis928

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 33

  1. Taylor, 2012, HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms, Clin Infect Dis, 55, S33, 10.1093/cid/cis367 · DOI
  2. Thomas, 2011, Hepatitis C in HIV-infected individuals: cure and control, right now, J Int AIDS Soc, 14, 22, 10.1186/1758-2652-14-22 · DOI
  3. Kim, 2012, An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection, J Infect Dis
  4. Grebely, 2011, Management of HCV and HIV infections among people who inject drugs, Curr Opin HIV AIDS, 6, 501, 10.1097/COH.0b013e32834bcb36 · DOI
  5. Hellard, 2009, Hepatitis C treatment for injection drug users: a review of the available evidence, Clin Infect Dis, 49, 561, 10.1086/600304 · DOI · Paper page
  6. Martin, 2011, Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility, J Hepatol, 54, 1137, 10.1016/j.jhep.2010.08.029 · DOI · Paper page
  7. Martin, 2012, Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations, Hepatology, 55, 49, 10.1002/hep.24656 · DOI · Paper page
  8. Grebely, 2009, Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents, J Viral Hepat, 16, 352, 10.1111/j.1365-2893.2009.01080.x · DOI · Paper page
  9. Mehta, 2006, Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic, AIDS, 20, 2361, 10.1097/QAD.0b013e32801086da · DOI
  10. Fishbein, 2004, Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection, J Acquir Immune Defic Syndr, 37, 1367, 10.1097/01.qai.0000131932.21612.49 · DOI
  11. Grebely, 2008, Barriers associated with the treatment of hepatitis C virus infection among illicit drug users, Drug Alcohol Depend, 93, 141, 10.1016/j.drugalcdep.2007.09.008 · DOI · Paper page
  12. Swan, 2010, Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration, AIDS Patient Care STDS, 24, 753, 10.1089/apc.2010.0142 · DOI · Paper page
  13. Myles, 2011, Physicians’ attitudes and practice toward treating injection drug users with hepatitis C: results from a national specialist survey in Canada, Can J Gastroenterol, 25, 135, 10.1155/2011/810108 · DOI
  14. Litwin, 2007, Hepatitis C management by addiction medicine physicians: results from a national survey, J Subst Abuse Treat, 33, 99, 10.1016/j.jsat.2006.12.001 · doi:10.1016/j.jsat.2006.12.001
  15. Lambert, 2011, General practitioner attitudes to prescribing hepatitis C antiviral therapy in a community setting, Aust J Prim Health, 17, 282, 10.1071/PY10069 · doi:10.1071/py10069
  16. Osilla, 2011, Patient and provider characteristics associated with the decision of HIV coinfected patients to start hepatitis C treatment, AIDS Patient Care STDS, 25, 533, 10.1089/apc.2011.0048 · doi:10.1089/apc.2011.0048
  17. Oser, 2012, Correlates of hazardous drinking among veterans with and without hepatitis C, J Behav Med, 35, 634, 10.1007/s10865-011-9394-9 · DOI
  18. Wagner, 2009, Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection, AIDS Patient Care STDS, 23, 715, 10.1089/apc.2009.0049 · DOI
  19. Treloar, 2012, Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs, Drug Alcohol Rev, 31, 918, 10.1111/j.1465-3362.2012.00468.x · doi:10.1111/j.1465-3362.2012.00468.x
  20. Osilla, 2009, Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment, AIDS Patient Care STDS, 23, 993, 10.1089/apc.2009.0153 · DOI
  21. Treloar, 2010, Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals, J Viral Hepat, 17, 839, 10.1111/j.1365-2893.2009.01250.x · DOI
  22. Ward, 2012, Hepatitis C virus prevention, care, and treatment: from policy to practice, Clin Infect Dis, 55, S58, 10.1093/cid/cis392 · DOI
  23. Litwin, 2012, Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk, Dig Liver Dis, 44, 497, 10.1016/j.dld.2011.12.014 · DOI
  24. Rockstroh, 2008, European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults, HIV Med, 9, 82, 10.1111/j.1468-1293.2007.00535.x · DOI · Paper page
  25. Arora, 2011, Outcomes of treatment for hepatitis C virus infection by primary care providers, N Engl J Med, 364, 2199, 10.1056/NEJMoa1009370 · DOI · Paper page
  26. McGovern, 2012, Editorial commentary: hepatitis C virus and the infectious disease physician: a perfect match, Clin Infect Dis, 55, 414, 10.1093/cid/cis378 · doi:10.1093/cid/cis378
  27. Knott, 2006, Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes, Am J Gastroenterol, 101, 2254, 10.1111/j.1572-0241.2006.00731.x · DOI
  28. Larrey, 2011, Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-alpha2a and ribavirin, Clin Gastroenterol Hepatol, 9, 781, 10.1016/j.cgh.2011.05.022 · DOI
  29. Grebely, 2007, Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users, J Gastroenterol Hepatol, 22, 1519, 10.1111/j.1440-1746.2007.05032.x · DOI
  30. Grebely, 2010, Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support, Eur J Gastroenterol Hepatol, 22, 270, 10.1097/MEG.0b013e32832a8c4c · DOI
  31. Sylvestre, 2007, Integrating HCV services for drug users: a model to improve engagement and outcomes, Int J Drug Policy, 18, 406, 10.1016/j.drugpo.2007.01.010 · DOI
  32. Norman, 2008, The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users, Harm Reduct J, 5, 8, 10.1186/1477-7517-5-8 · doi:10.1186/1477-7517-5-8
  33. Dore, 2012, The changing therapeutic landscape for hepatitis C, Med J Aust, 196, 629, 10.5694/mja11.11531 · doi:10.5694/mja11.11531

Metadata

Authors
Grebely, J., Oser, M., Taylor, L. E., & Dore, G. J.
Venue
The Journal of Infectious Diseases
Published
2013-03-15
Volume
207
Issue
suppl_1
Pages
S19-S25
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2117027295
Cited by
182
References
1
FWCI
9.54
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels. https://app.cochat.ai/papers/10.1093/infdis/jis928
The paper
Grebely, J., Oser, M., Taylor, L. E., & Dore, G. J. (2013). Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jis928

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.